Similarly, Zhang et al. reported it is via targeting EIF4E in HCC cells, that the inhibited miR-15a-5p promoted chemoresistance to pirarubicin (Zhang et al., 2021). The gene discussed is EIF4E; the disease is hepatocellular carcinoma.